Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD Diagnostic Test (Age, Sex, Gene Expression Score ASGES).
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- CardioDx
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Age/Sex/Gene expression score (ASGES) difference between peak exercise and baseline
Overview
Brief Summary
This is a prospective, single-center study that aims to evaluate the acute and delayed effect of exercise stress testing on the peripheral gene expression (PGE) levels using a predefined gene set established in the Corus CAD (Age/Sex/Gene Expression score - ASGES) test in subject with known obstructive coronary artery disease (CAD) and in control subjects (without known CAD).
Detailed Description
This is a prospective, single-center study. This protocol is a pilot study to investigate the effects of "acute" exercise (by exercise stress testing; modified Bruce protocol) on peripheral gene expression (PGE) levels as measured by Corus CAD score (Age/Sex/Gene Expression score - ASGES). Subjects will have blood sampling at baseline, at peak exercise, within 30 to 60 minutes post-exercise, at 24-36 hours post-exercise. The study will be stratified by presence of CAD and gender. An equal number of subjects with known CAD and normal controls will be enrolled. Equally, an equal number of men and women will be included. A screening CBC and HgbA1c will be performed to ensure the subject meets the intended use instruction for Corus CAD (ASGES). Data collection will include presence or absence of ECG ischemia with testing, as well as heart rate and blood pressure response to exercise with other ECG and dynamic variables. There will be four blood samples taken per subject as shown in the figure below.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 45 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Ages 45-75 years old
- •Able to perform an adequate exercise stress test
- •Subjects with no known CAD and subjects with known CAD subjects
Exclusion Criteria
- •Known severe CAD that will be unsafe to exercise stress patient
- •Current MI or high-risk acute coronary syndrome (including high-risk unstable angina
- •NYHA class III or IV congestive heart failure
- •Severe regurgitant or stenotic cardiac valvular lesion
- •Severe left ventricular systolic dysfunction
- •Active systemic infection in the preceding 2 months or chronic infection (e.g. HIV, Hepatitis B or C, Tuberculosis)\*\*.
- •Protocol-specified rheumatologic, autoimmune or hematologic conditions
- •Known or suspected diabetes mellitus or documented Hemoglobin A1C (A test for people with diabetes that monitors their average blood sugar levels over a period of two to three months) percent within last 6 months; presume normal HgbA1c (used as a standard tool to determine blood sugar control for patients with diabetes.) if none documented.
- •Total WBC 11,000/ul from a CBC drawn within 7 days of enrollment
- •Inadequate exercise stress test.
Outcomes
Primary Outcomes
Age/Sex/Gene expression score (ASGES) difference between peak exercise and baseline
Time Frame: up to 1 months
Secondary Outcomes
No secondary outcomes reported